Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Tuesday, March 16, 2010

NANJING, China, March 1 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group

(NYSE: SCR), a leading pharmaceutical company specializing in the development,

manufacturing, and marketing of branded generic and proprietary

pharmaceuticals in China, today announced that it will report its unaudited

fin

http://digg.com/u1Od4Q